Rachel Courtney

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer

Keith T. Flaherty, Patricia LoRusso, Angela DeMichele et al. · Clinical Cancer Research · 2011 · 361 citations

Medicine, Oncology, Pharmacology +17

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

Rachel Courtney, David Wexler, Elaine Radwanski et al. · British Journal of Clinical Pharmacology · 2003 · 325 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

Rachel Courtney, Sudhakar M. Pai, Mark Laughlin et al. · Antimicrobial Agents and Chemotherapy · 2003 · 301 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

John P. Leonard, Ann S. LaCasce, Mitchell R. Smith et al. · Blood · 2012 · 297 citations · Full text

Medicine, Oncology, Pharmacology +14

Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects

Philip A. Krieter, Brian Flannery, Timothy J Musick et al. · Antimicrobial Agents and Chemotherapy · 2004 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17